PD-L1 / CD274 antibody (IHC prefer, N-terminal)
Product Includes
Application Dilution
Immunofluorescence 1:100 – 1:300
Immunohistochemistry (Paraffin) 1:100
Storage
100mM Tris Glycine, 25% Glycerol (pH7). 0.025% ProClin 300 was added as a preservative
Specificity / Sensitivity
Source / Immunogen
This gene encodes an immune inhibitory receptor ligand that is expressed by hematopoietic and non-hematopoietic cells, such as T cells and B cells and various types of tumor cells. The encoded protein is a type I transmembrane protein that has immunoglobulin V-like and C-like domains. Interaction of this ligand with its receptor inhibits T-cell activation and cytokine production. During infection or inflammation of normal tissue, this interaction is important for preventing autoimmunity by maintaining homeostasis of the immune response. In tumor microenvironments, this interaction provides an immune escape for tumor cells through cytotoxic T-cell inactivation. Expression of this gene in tumor cells is considered to be prognostic in many types of human malignancies, including colon cancer and renal cell carcinoma. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2015]
Title | |
---|---|
No data. |
Reviews
Customer feedback Image
Application : FFPE immunohistochemistry
Condition / Dilution : 1-100 Epitope Retrieval methods: EDTA
Sample : Human Colon Carcinoma
Data from : Li-Tzung Biotechnology. Co
Customer feedback Image
Application : Immunoprecipitation
Sample : MDA-MB-231
Data from : National Defense Medical Center